David Gordon
2020 - Aclaris Therapeutics
In 2020, David Gordon earned a total compensation of $760.2K as Former Chief Medical Officer at Aclaris Therapeutics, a 45% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $189,561 |
---|---|
Option Awards | $105,356 |
Salary | $412,090 |
Stock Awards | $41,818 |
Other | $11,400 |
Total | $760,225 |
Gordon received $412.1K in salary, accounting for 54% of the total pay in 2020.
Gordon also received $189.6K in non-equity incentive plan, $105.4K in option awards, $41.8K in stock awards and $11.4K in other compensation.
Rankings
In 2020, David Gordon's compensation ranked 9,683rd out of 13,090 executives tracked by ExecPay. In other words, Gordon earned more than 26.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,683 | 26th |
Manufacturing | 4,168 | 26th |
Chemicals And Allied Products | 1,708 | 24th |
Drugs | 1,497 | 23rd |
Pharmaceutical Preparations | 1,103 | 24th |
Gordon's colleagues
We found three more compensation records of executives who worked with David Gordon at Aclaris Therapeutics in 2020.
News
Aclaris Therapeutics CEO Neal Walker's 2021 pay jumps 326% to $6.9M
April 21, 2022
Coffee Holding Co CEO Andrew Gordon's 2021 pay slips 10% to $380K
February 28, 2022
Coffee Holding Co CEO Andrew Gordon's 2020 pay falls 66% to $421K
March 29, 2021
Aclaris Therapeutics CEO Neal Walker's 2019 pay falls 28% to $3.2M
April 23, 2020
Coffee Holding Co CEO Andrew Gordon's 2019 pay jumps 220% to $1.2M
February 28, 2020
Coffee Holding Co Secretary David Gordon's 2018 pay rises 2% to $389K
February 28, 2019